Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy.

Griffith TN, Varela-Nallar L, Dinamarca MC, Inestrosa NC.

Curr Med Chem. 2010;17(5):391-406. Review.

PMID:
20015041
2.

[Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].

Bouron A, Lorrain E.

Encephale. 2014 Apr;40(2):108-13. doi: 10.1016/j.encep.2013.03.004. Epub 2013 Jun 29. Review. French.

PMID:
23816060
3.

Role of hyperforin in the pharmacological activities of St. John's Wort.

Zanoli P.

CNS Drug Rev. 2004 Fall;10(3):203-18. Review.

4.
5.

St. John's wort.

Lawvere S, Mahoney MC.

Am Fam Physician. 2005 Dec 1;72(11):2249-54. Review.

6.

Current St John's wort research from mode of action to clinical efficacy.

Müller WE.

Pharmacol Res. 2003 Feb;47(2):101-9. Review.

PMID:
12543057
7.

Hyperforin: more than an antidepressant bioactive compound?

Medina MA, Martínez-Poveda B, Amores-Sánchez MI, Quesada AR.

Life Sci. 2006 Jun 6;79(2):105-11. Epub 2006 Jan 24. Review.

PMID:
16438991
8.

St John's wort: Prozac from the plant kingdom.

Di Carlo G, Borrelli F, Ernst E, Izzo AA.

Trends Pharmacol Sci. 2001 Jun;22(6):292-7. Review.

PMID:
11395157
9.

Hyperforin: To Be or Not to Be an Activator of TRPC(6).

Friedland K, Harteneck C.

Rev Physiol Biochem Pharmacol. 2015;169:1-24. doi: 10.1007/112_2015_25. Review.

PMID:
26384487
10.

[Hyperforin in St. John's wort--drug, extraction and preparations].

Lang F, Biber A, Erdelmeier C.

Pharm Unserer Zeit. 2002;31(5):512-4. Review. German. No abstract available.

PMID:
12369170
11.

Hyperforin, a new lead compound against the progression of cancer and leukemia?

Quiney C, Billard C, Salanoubat C, Fourneron JD, Kolb JP.

Leukemia. 2006 Sep;20(9):1519-25. Epub 2006 Jun 22. Review.

PMID:
16791262
12.

Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).

Nahrstedt A, Butterweck V.

J Nat Prod. 2010 May 28;73(5):1015-21. doi: 10.1021/np1000329. Review.

PMID:
20408551
13.

Hypericum perforatum, a source of neuroactive lead structures.

Verotta L.

Curr Top Med Chem. 2003;3(2):187-201. Review.

PMID:
12570773
14.

Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.

Sarris J, Kavanagh DJ.

J Altern Complement Med. 2009 Aug;15(8):827-36. doi: 10.1089/acm.2009.0066. Review.

PMID:
19614563
15.

The antidepressant mechanism of Hypericum perforatum.

Mennini T, Gobbi M.

Life Sci. 2004 Jul 16;75(9):1021-7. Review.

PMID:
15207650
16.

Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases.

Ebner FH, Mariotto S, Darra E, Suzuki H, Cavalieri E.

Cent Nerv Syst Agents Med Chem. 2011 Mar 1;11(1):2-7. Review.

PMID:
20812906
17.

Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.

Li L, Zhang W, Cheng S, Cao D, Parent M.

Mol Neurobiol. 2012 Aug;46(1):64-77. doi: 10.1007/s12035-012-8253-1. Epub 2012 Mar 15. Review.

Supplemental Content

Support Center